The use of mycobacteriophage 33D to differentiate strains of BCG from isolates of Mycobacterium bovis was investigated. The procedure was found to be reproducible and, using the commercially available media described, can be recommended for use in mycobacterial reference laboratories.
The current use of BCG in the treatment of tumors (2, 10) has stimulated investigations with the different strains of BCG. A recent report of local and disseminated infection in cancer patients undergoing BCG therapy (2) and the reinvestigation of the variation in the degree of virulence among different strains of BCG (8) raises the question of the identification of BCG isolates submitted to the diagnostic laboratories. At the present time the only means of differentiating strains of BCG from virulent strains of Mycobacterium bovis is animal pathogenicity tests (6, 9) , which are both time consuming and expensive. Mycobacteriophage 33D has been reported to differentiate strains of BCG from M. bovis (3, 4) . The present study was undertaken to evaluate the use of mycobacteriophage 33D for the separation of recently isolated strains of M. bovis from known strains of BCG and to modify the procedure so that it could be used in reference laboratories performing tests were obtained from W. B. Redmond. High-titered phage lysates were prepared by the methods described earlier (5, 7) . All cultures were grown in 7H9 broth, 7H9 broth base (Difco), and 0.25% Tween 80 (Atlas Powder Co.). Before phage testing, the cultures were centrifugated at 5,000 rpm for 15 min and the pelleted cells were resuspended in heart infusion base broth (heart infusion base [Difco] supplemented with 0.02 M calcium chloride). Phage tests were performed by using the softagar overlay method of Adams (1) . The hard basal medium was oleic acid-albumin agar base (BBL) supplemented with Dubos oleic acidalbumin complex (Difco). The soft agar was Dubos broth base, without Tween 80 (Difco), supplemented with 0.7% agar. These media were prepared and used as described earlier (5) . The routine test dilution of each phage was determined on the respective phage host strain (7) .
For phage testing, 0.5 ml of the heart infusion base bacterial suspension (approximately 107 bacteria/ml) was placed in the soft-agar plate.
The soft agar was allowed to harden at room temperature. The inoculated plates were placed in a 37 C incubator and dried overnight. The next day fresh routine test dilutions were made for each of the two phages and the inoculated plates were spotted with the phages. The plates were then returned to the 37 C incubator. The plates were examined for lysis from the 4th through 7th days of incubation.
The results of the phage tests are listed in Table 1 . All of the 133 mycobacterial strains tested were lysed by mycobacteriophage DS6A.
The strains of M. tuberculosis and M. bovis were also lysed by phage 33D whereas the strains of BCG were not. The results of the phage susceptibility tests are listed in Table 1 . Each of 133 strains of mycobacteria was phage tested three separate times to test the reproducibility of the phage testing, and the results were the same as in Table 1 . Also, both phage DS6A and 33D are quite stable in the undiluted lysates and can be stored in the refrigerator for 12 months without a significant loss of titer.
The results of this study confirm the report of Buraczewska et al. (3, 4) on the use of mycobacteriophage 33D as a rapid and simple method to distinguish wild strains of M. bovis from strains of BCG. The stability of the two mycobacteriophages and the use of commercially available media described here makes the phage test bovis for this study.
